The 2022 French Consensus Statement, developed by the SFE and SFEDP, updates guidelines for diagnosing and managing Cushing’s syndrome, emphasizing targeted screening for high-suspicion cases and the use of multiple first-line biochemical tests. Key recommendations focus on determining etiology and utilizing surgical resection as the primary treatment, with specific protocols for complex, pediatric, and genetic cases. Access the full document through the ODPC Endocrinology portal .
This is for informational purposes only. For medical advice or diagnosis, consult a professional. AI responses may include mistakes. Learn more
The 2022 French Consensus Statement, developed by the SFE and SFEDP, updates guidelines for diagnosing and managing Cushing’s syndrome, emphasizing targeted screening for high-suspicion cases and the use of multiple first-line biochemical tests. Key recommendations focus on determining etiology and utilizing surgical resection as the primary treatment, with specific protocols for complex, pediatric, and genetic cases. Access the full document through the ODPC Endocrinology portal .
This is for informational purposes only. For medical advice or diagnosis, consult a professional. AI responses may include mistakes. Learn more Download French Consensus statement Cushing 2022 pdf